Search results

5 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Making the case for adjuvant chemotherapy for older patients with colon cancer
Hy Muss, MD, and Debra Bynum, MD, co-authored an editorial in the July 20, 2012 issue of the Journal of Clinical Oncology.
Located in News / 2012 News
UNC scientists describe protein that protects against colon cancer
Chapel Hill - A family of proteins is yielding new information about how it contributes to the development of gastrointestinal disease and cancer. A team of UNC scientists reports that in pre-clinical models, the absence of a protein called NLRP12 significantly increases susceptibility to colitis-associated colon cancer.
Located in News / 2012 News
UNC scientists collaborate on colon cancer therapy comparative effectiveness study
In 2008 UNC and Harvard University’s Brigham and Women’s Hospital in Boston were selected by the U.S. Agency for Healthcare Research and Quality to carry out accelerated practical studies examining the comparative effectiveness of cancer treatments. The collaboration is called the Cancer Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) Comparative Effectiveness Consortium.
Located in News / 2012 News
UNC Lineberger patient Morgan Throckmorton talks with WRAL about her diagnosis, clinical trials
UNC Lineberger patient Morgan Throckmorton was diagnosed with colon cancer in 2009 when she was 24 years old. She is now part of a UNC-led trial to test a new drug, Regorafinib.
Located in News / 2011 News
Lifetime Televison looks at colon cancer, talks with Dr. Richard Goldberg
Richard Goldberg, MD, physician-in-chief of the N.C. Cancer Hospital, talks with Kristy Villa, one of the hosts of Lifetime Television’s “The Balancing Act" about colon cancer.
Located in News / 2011 News